Phase 3 Trial for Melanoma Treatment
Merck & Co. (MRK) and Moderna Inc. (MRNA) have announced the initiation of a Phase 3 trial to evaluate the efficacy of Moderna's V940 in combination with Merck's Keytruda as…
Merck & Co. (MRK) and Moderna Inc. (MRNA) have announced the initiation of a Phase 3 trial to evaluate the efficacy of Moderna's V940 in combination with Merck's Keytruda as…